|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.810 USD | +2.84% |
|
-9.50% | +21.48% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
EPS & Dividend: Marker Therapeutics, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -6.1 | -5.5 | -3.58 | -1.19 | -0.9433 | -1.44 | -0.9533 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 14.500 | 9.502 | 2.659 | 3.110 | 1.810 | 1.810 | 1.810 |
| Nbr of stocks (in thousands) | 4,803 | 8,308 | 8,540 | 10,707 | 16,673 | 16,673 | - |
| Announcement Date | 09/03/21 | 17/03/22 | 22/03/23 | 31/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Marker Therapeutics, Inc.
| 11/03/2026 | Q4 2025 Earnings Release (Projected) |
| 19/05/2026 | Q1 2026 Earnings Release (Projected) |
| 11/11/2026 | Q3 2026 Earnings Release (Projected) |
| 18/05/2027 | Q1 2027 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -1.87x | - | - | |
| 0.88% | 0.99% | 39.23x | 4.04x | 5.69x | |
| - | - | - | - | - | |
| -.--% | -.--% | 33.98x | 6.47x | 3.36x | |
| -.--% | -.--% | 103.5x | 9.36x | 6.63x | |
| 0.35% | 0.36% | 55.58x | 2.66x | 11.4x | |
| -.--% | -.--% | -22.06x | 15.02x | 6405.73x | |
| - | - | - | - | - | |
| -.--% | -.--% | 41.75x | 41.69x | 6.77x | |
| - | - | - | - | - | |
| Average | 0.2% | 0.22% | 35.73x | 13.21x | 1,073.26x | |
| Weighted average by Cap. | 0.27% | 0.3% | 45.64x | 9.89x | 767.07x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition